logo
Black Canadians have highest avoidable hospitalization rates: StatCan data

Black Canadians have highest avoidable hospitalization rates: StatCan data

CTV News11 hours ago

Treatment rooms in the emergency department at Peter Lougheed hospital are pictured in, Calgary, Alta., Tuesday, Aug. 22, 2023. THE CANADIAN PRESS/Jeff McIntosh
TORONTO — New data from Statistics Canada shows Black Canadians have had the highest rates of avoidable hospitalizations in the country — something experts say underscores the need for more equitable health services for the Black community.
A report released June 18 shows that over an eight-year period, Black Canadians were admitted to hospital for treatable health conditions such as asthma, diabetes and hypertension at higher rates than other racial groups and non-racialized people.
In the most recent data collected in 2023/2024, Black men and boys were admitted at a rate of 272 hospitalizations per 100,000 people while Black women and girls saw a rate of 253 per 100,000 people.
Other racialized people including South Asian, Chinese and Filipino Canadians had significantly lower rates. The lowest was among the Chinese population, in which men and boys had 65 hospitalizations per 100,000 people, and women and girls recorded 52 per 100,000 people.
Non-racialized people had the second-highest rate of avoidable hospital admissions in 2023, reaching 257 per 100,000 among men and 226 per 100,000 among women, the report states.
Notisha Massaquoi, an assistant professor of health education and promotion at the University of Toronto, says the data shines a light on the health equity crisis for Black Canadians who face significant barriers to primary care.
'(This is) a population that has experienced an enormous amount of racism in the health-care system,' said Massaquoi, who studies access to health-care services for Black Canadians in the Greater Toronto Area.
'There's a lack of trust in terms of going to a primary health-care setting or going to see a primary health-care provider, and when a community has experienced a lot of marginalization in the health-care system, what they do is avoid going until it's too late.'
Black Canadians might avoid seeking routine care because there is also a lack of Black health-care providers, said Massaquoi, noting better survival rates and health outcomes when a Black patient has a Black primary caregiver.
StatCan data shows that in 2023, the most updated information available, 72 per cent of Black Canadians had access to a primary health care provider. That's compared to 84 per cent of non-racialized Canadians.
The Canadian Medical Association says it doesn't keep track of the number of Black physicians in the country, but data published in 2020 by the Academic Medicine Journal — the peer-reviewed journal of the Association of American Medical Colleges — estimated that 2.3 per cent of practising physicians in Ontario were Black in 2018.
StatCan's report doesn't provide the specific reasons for hospitalizations, but a member of the senior leadership team at Women's College Hospital in Toronto says Black populations are disproportionately affected by chronic illnesses.
The reasons for that are complicated, said Dr. Cynthia Maxwell, a past-president of the Black Physicians Association of Ontario.
Maxwell said chronic illnesses can sometimes be traced to hurdles navigating the health-care system. Some Black communities also have fewer grocery store options, making access to nutritious food difficult, or are in areas more exposed to environmental toxins, which can lead to higher rates of respiratory problems.
Massaquoi and Maxwell both stressed the need for more Black health-care providers and Black-oriented clinics, saying many patients feel more comfortable visiting environments where there's less risk of racism.
Such an increase could also help train other doctors on the specific needs of Black patients.
'We will likely never have enough Black health-care providers to provide access to all Black community members, so it is important for all allies in the health system to engage in and learn about cultural safety and competencies that will help drive better health-care outcomes,' Maxwell said.
Maxwell linked less access to primary care to higher mortality rates of serious diseases, such as among Black women with breast and cervical cancer.
'We know Black women have less access to screening for conditions such as breast cancer and cervical cancer, which are major issues and have high morbidity and mortality in Black communities,' she said.
'A condition is identified typically in the primary care setting,' she said, noting that's where a patient is referred to a specialist for serious conditions.
Maxwell said it was important to collect better race-based patient data in order to identify issues unique to each community.
'Without the … race-specific data, you can't really get to the nuances of what the particular issues are within a community and what it means for a community to be disproportionately affected, either by a health condition or by the outcome of treatment for a health condition,' Maxwell said.
Massaquoi said Black health-care advocates have 'constantly' begged for better race-based data collection.
'What we want to see as members of the Black community are the interventions that are going to be developed and designed so we're no longer just getting this trauma type of data that keeps telling us over and over in every manner how badly we're doing.'
This report by The Canadian Press was first published June 29, 2025.
Cassidy McMackon, The Canadian Press

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New technology allows menstrual pads to screen for cervical cancer
New technology allows menstrual pads to screen for cervical cancer

CTV News

time44 minutes ago

  • CTV News

New technology allows menstrual pads to screen for cervical cancer

(CT Murphy has been exploring the use of nanomaterials in menstrual pads to non-invasively detect human papillomavirus (HPV), a leading cause of cervical cancer. Image courtsey: CELLECT Laboratories Inc.) Innovative new technology could soon mean that screening for cervical cancer won't be as uncomfortable as a Pap test, according to two Waterloo, Ont., researchers. CELLECT Laboratories co-founders CT Murphy and Ibukun Elebute have been exploring the use of nanomaterials in menstrual pads to non-invasively detect human papillomavirus (HPV), a leading cause of cervical cancer. Murphy says her first experience with a Pap test prompted her to create this innovation as a final-year project studying nanotechnology at the University of Waterloo (uWaterloo). 'They are one of the most uncomfortable and archaic experiences I've ever had in the medical industry,' Murphy told in a phone interview. 'I was really taken aback with how little pain management there was.' Murphy later partnered with Elebute, a fellow uWaterloo alum with a background in biomedical and mechanical engineering, as well as business, to found CELLECT Laboratories Inc. Ibukun Elebute and CT Murphy. (Ibukun Elebute and CT Murphy. Image courtsey: CELLECT Laboratories Inc.) In the last two years, their nanomaterials research has won over $150,000 in funding at pitch competitions worldwide. 'I think it's been a very recent advent of people actually looking into women's health and realizing what a massive disparity there is,' Murphy said. 'Women are desperate for proper health care that is made for them, by them and that they can trust (…) this technology is not only wanted, but desperately needed.' 'It's clear that we are not building in isolation,' said Elebute. 'We're standing on the shoulders of a growing community that's pushing for real change in women's health, and that makes all the difference.' Cervical cancer screening in Canada Murphy says that modernization could help address low screening rates for cervical cancer – as it's one of the reasons contributing to what the Canadian Cancer Society calls the fastest increasing cancer in women. '(Women's) lives are at stake because of certain social stigmas surrounding one of the main diagnostic techniques for cervical cancer,' Murphy said. 'I think innovating in a way that makes (screening) more inviting and easier to use will mean a genuine improvement in not only quality of life, but the chances of survival for tons of women who are affected by HPV and cervical cancer every single day.' The incidence rate of cervical cancer has risen 3.7 per cent per year since 2015, the first significant increase since 1984 and a 'concerning' trend that a recent Canadian Medical Association Journal report notes is largely preventable. 'Not even optimally using technology' In Canada, several initiatives have already been introduced to address the rise in cervical cancer, including increased awareness of HPV vaccination and a shift to HPV testing rather than Pap or cytology tests. HPV testing requires less frequent screening and targets the high-risk types of HPV that lead to cervical cancer. Ontario, British Columbia, P.E.I. and Northwest Territories have all transitioned from Pap tests to HPV testing, and Quebec is offering the service in some regions, with plans to fully adopt it province-wide. B.C. is the first to offer at-home self-testing covered by the province, an option expected to be available in Ontario and New Brunswick in the future. All other provinces are in various stages of making the switch. Dr. Anna Wilkinson, a family physician and oncologist at The Ottawa Hospital, says the transition has been slow to come, nationally. Despite a decade data showing it to be more effective than cytology, federal screening guidelines recommend against HPV testing. Dr. Wilkinson says those guidelines are 12 years out of date. 'We're not even optimally using technology that's already proven and known,' she told 'Cervical cancer is almost entirely preventable, yet each year in Canada, many women die from it or undergo difficult treatments with lifelong side effects. We must modernize our national guidelines to include HPV vaccination, HPV cervical screening and self-screening, so that cervical cancer can be eradicated in Canada.' Current initiatives don't address all issues While Murphy and Elebute acknowledge the importance of recent modernization initiatives, they say the current self-testing model does not fully address the issues they aim to tackle. HPV testing kits may still trigger the same discomfort and stigma as Pap tests, Murphy notes, especially for survivors of sexual abuse, or those experiencing gender dysphoria. 'The swab simply does not alleviate the correct pain points,' she said. 'We are providing a noninvasive and familiar alternative that will incentivize those who do not seek out Pap smears to get tested for HPV.' That said, abnormal test results may still necessitate more invasive screening, such as a colposcopy or biopsy. 'Depending on what you have or what you want to look for, you might need to have one of those uncomfortable exams,' said Dr. Amanda Selk, an obstetrician gynecologist at Women's College Hospital in Toronto, in an interview. 'If you actually do have a high-risk HPV strain, then you have to have an exam with a speculum where we look at your cervix with a microscope to see if there's any pre-cancer happening there.' Coexisting in the current landscape With their prototype three years into testing and soon to move on to clinical trials, Murphy and Elebute say their intention is not to replace current models, but to coexist alongside existing lab workflows. 'Our goal is to enhance what's already available by making high-quality sample collection more accessible, comfortable and compatible with the realities of people's lives,' Elebute said. 'When we think about the future, we see CELLECT as a powerful complement to existing self-testing tools - expanding access, improving user experience and ultimately helping more people get screened earlier and more reliably.' In addition to screening for HPV and cervical cancer, Elebute says menstrual blood could be used as a diagnostic tool for other female reproductive conditions, transforming women's health care. 'We see different fluids used (in health care): blood, urine, stool; and you begin to wonder why the one thing that we're able to collect pretty much every month is not being used,' Elebute said. 'It's almost like a gold mine that we need to use to catch up on all the years we've fallen behind in women's health.'

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

National Post

timean hour ago

  • National Post

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

Article content ROCKVILLE, Md. & EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will host a webcast and conference call on June 30, 2025, at 8:30 a.m. ET to discuss AUR200 Phase 1 study results. The link to the webcast is available here. To join the conference call, please dial 877-407-9170/+1 201-493-6756. Click here for participant International Toll-Free access numbers. A replay of the webcast will be available on Aurinia's website. Article content About Aurinia Article content Article content Aurinia is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS ® (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing AUR200, a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. Article content Article content Article content Article content Article content Article content

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store